“…It was detected that 15 studies with 1938 cases and 4450 controls were performed in European countries [ 15 , 34 – 36 , 38 , 40 , 41 , 44 , 49 , 59 , 60 , 71 ] which among these 15 studies, Turpeinen et al [ 36 ] conducted an association study in different city of Finland (Turku, Tampere and Oulu) and reported all data separately, including genotype and allele frequency; thus we considered each population as a separate study. Moreover, 13 studies out of 34 eligible studies were carried out in Asian populations [ 42 , 46 , 48 , 56 – 58 , 62 – 64 , 67 – 70 ], 3 studies were in Americans [ 43 , 61 , 66 ] and three studies were in Africans [ 52 , 53 , 65 ]. No significant association between BsmI polymorphism and T1DM risk were found under all genotype models for the overall population.…”